Cargando…
Design and synthesis of nanoscaled IQCA-TAVV as a delivery system capable of antiplatelet activation, targeting arterial thrombus and releasing IQCA
BACKGROUND: Arterial thrombosis has been associated with a series of pathological conditions, and the discovery of arterial thrombosis inhibitor is of clinical importance. METHODS: By analyzing the pharmacophores of anti-platelet agents, thrombus targeting peptide and anti-thrombotic nano-systems 3S...
Autores principales: | Wu, Jianhui, Zhu, Haimei, Yang, Guodong, He, Jianhong, Wang, Yuji, Zhao, Shurui, Zhang, Xiaoyi, Gui, Lin, Zhao, Ming, Peng, Shiqi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833776/ https://www.ncbi.nlm.nih.gov/pubmed/29520141 http://dx.doi.org/10.2147/IJN.S150205 |
Ejemplares similares
-
IQCA-TAVV: To explore the effect of P-selectin, GPIIb/IIIa, IL-2, IL-6 and IL-8 on deep venous thrombosis
por: Wu, Jianhui, et al.
Publicado: (2017) -
N-(3-hydroxymethyl-β-carboline-1-yl-ethyl- 2-yl)-l-Phe: development toward a nanoscaled antitumor drug capable of treating complicated thrombosis and inflammation
por: Wu, Jianhui, et al.
Publicado: (2017) -
Nano-scaled MTCA-KKV: for targeting thrombus, releasing pharmacophores, inhibiting thrombosis and dissolving blood clots in vivo
por: Zhao, Shurui, et al.
Publicado: (2019) -
ATIQCTPC: a nanomedicine capable of targeting tumor and blocking thrombosis in vivo
por: Xu, Xinyi, et al.
Publicado: (2017) -
Cu(2+)-RGDFRGDS: exploring the mechanism and high efficacy of the nanoparticle in antithrombotic therapy
por: Wu, Jianhui, et al.
Publicado: (2015)